Greenwich Lifesciences Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
GLSI Nasdaq 2836 https://greenwichlifesciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Greenwich Lifesciences Inc

Companies Like Greenwich LifeSciences (NASDAQ:GLSI) Are In A Position To Invest In Growth - Feb 1st, 2023 10:30 am
Insider Buying: The Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO, CFO & Director Just Bought US$61k Worth Of Shares - Jan 5th, 2023 10:10 am
Greenwich LifeSciences Provides Year End Update - Dec 29th, 2022 11:48 am
After Golden Cross, Greenwich LifeSciences, Inc. (GLSI)'s Technical Outlook is Bright - Dec 21st, 2022 2:55 pm
Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023 - Dec 1st, 2022 11:00 am
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) insiders seem bullish, own 59% and have been buying more recently - Oct 28th, 2022 10:53 am
10 Best Immunotherapy Stocks To Buy Now - Oct 11th, 2022 3:54 pm
Bullish insiders at Greenwich LifeSciences, Inc. (NASDAQ:GLSI) loaded up on US$1.4m of stock earlier this year - Sep 30th, 2022 1:22 pm
We're Not Very Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Rate - Aug 18th, 2022 11:59 am
Greenwich LifeSciences Announces Activation of Clinical Sites and Commencement of Phase III Clinical Trial - Aug 11th, 2022 2:30 pm
7 Short-Term Stocks to Buy for a Quick Profit - Aug 8th, 2022 8:32 pm
Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial - Aug 3rd, 2022 12:00 pm
Greenwich LifeSciences Provides Financing Strategy & Corporate Update - Jul 28th, 2022 10:00 am
Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed - Jul 12th, 2022 10:00 am
Greenwich LifeSciences Announces Suspension of Share Repurchase Program - Jul 11th, 2022 8:15 pm
Greenwich LifeSciences to Resume Stock Repurchase Program - May 23rd, 2022 11:00 am
Greenwich LifeSciences Provides Updates on Upcoming Phase III Clinical Trial & ASCO Meeting - May 23rd, 2022 10:00 am
Greenwich LifeSciences to Participate in Upcoming Jefferies, Wainwright, ASCO and BIO International Conferences - Apr 20th, 2022 10:10 am
Greenwich LifeSciences Presents Phase IIb Data, Published at AACR 2022, Further Supporting the Role of GP2 in Preventing Metastatic Breast Cancer - Apr 19th, 2022 10:21 am
Could The Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Ownership Structure Tell Us Something Useful? - Apr 1st, 2022 5:41 pm